Login

Crinetics Pharmaceuticals, Inc. SEC Filings

Filed On Filing
11 Sep 2026 15-12G
01 Sep 2026 Form 4: Wierenga Wendell, Director

Returned 122,071 shares to the issuer ($10.4M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.5M)

01 Sep 2026 Form 4: Vivaldi Coelho Rogerio, Director

Returned 19,225 shares to the issuer ($1.63M) · Disposed of 93,830 Stock Option (Right to Buy) (Disposition to Issuer) ($5.23M)

01 Sep 2026 Form 4: Okey Stephanie, Director

Returned 12,325 shares to the issuer ($1.05M) · Disposed of 105,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.09M)

01 Sep 2026 Form 4: Nichols Weston, Director

Returned 22,225 shares to the issuer ($1.89M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.5M)

01 Sep 2026 Form 4: Fust Matthew K, Director

Returned 28,761 shares to the issuer ($2.44M) · Disposed of 52,172 Stock Option (Right to Buy) (Disposition to Issuer) ($2.83M)

01 Sep 2026 Form 4: Deardorf Caren, Director

Returned 22,225 shares to the issuer ($1.89M) · Disposed of 89,455 Stock Option (Right to Buy) (Disposition to Issuer) ($5.25M)

01 Sep 2026 Form 4: Bedrosian Camille L, Director

Returned 22,225 shares to the issuer ($1.89M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.68M)

01 Sep 2026 Form 4: Kalofonos Isabel, Chief Commercial Officer

Returned 35,669 shares to the issuer ($3.03M) · Disposed of 152,500 Stock Option (Right to Buy) (Disposition to Issuer) ($6.6M)

01 Sep 2026 Form 4: Betz Stephen F., Chief Scientific Officer

Returned 137,936 shares to the issuer ($11.7M) · Disposed of 767,304 Stock Option (Right to Buy) (Disposition to Issuer) ($48M)

01 Sep 2026 Form 4: Schilke Tobin, Chief Financial & Infra. Ofcr.

Returned 79,427 shares to the issuer ($6.75M) · Disposed of 130,000 Stock Option (Right to Buy) (Disposition to Issuer) ($6.16M)

01 Sep 2026 Form 4: Struthers Richard Scott, Director

Returned 1,402,911 shares to the issuer ($119M) · Disposed of 1,939,822 Stock Option (Right to Buy) (Disposition to Issuer) ($110M)

01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS
01 Sep 2026 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support